OHBs, Capital

OHB's €510m Capital Raise Legacy Keeps Outweighing Its €1bn Space Win

Published on 09/03/2026 at 12:33 | Editorial boerse-global.de
OHB SE shares drop 30% in a month despite a €1bn IRIS² contract, as a €510.7m rights issue and expanded free float weigh on the stock.
OHB's €510m Capital Raise Legacy Keeps Outweighing Its €1bn Space Win Illustration mit AI erstellt.

The arithmetic of the past few weeks at OHB SE tells a story that no satellite contract, however prestigious, has so far been able to rewrite. Since the Bremen-based space group announced a €510.7m rights issue in mid-June, its shares have shed roughly a third of their value — and even a near-billion-euro order from the European IRIS² programme has failed to arrest the slide.

The stock was changing hands at €181.20 on Thursday, up 2.0 percent on the day but still deep in the red over every meaningful timeframe. The 30-day loss stands at 30 percent, while the weekly decline is 5.9 percent. Wednesday's close of €177.60 marked a 2.9 percent drop on the day, extending a sell-off that has its roots not in operations but in the company's capital structure.

A Summer of Dilution

The mechanics of the decline began on 15 June, when OHB's board, with supervisory board approval, unveiled a rights issue of up to 1,702,480 new shares — equivalent to 8.86 percent of share capital — priced at €300 apiece. The announcement alone knocked roughly ten percent off the share price. The first tranche of just over 1.6 million shares began trading on 26 June, the same day that KKR-affiliated Orchid Lux placed a substantial portion of its roughly 29 percent stake through an upsized bookbuilding at the identical price.

The Fuchs family, through its FFS, VOLPAIA and Martello Value vehicles, joined Orchid Lux in waiving its subscription rights. The result: free float is set to expand from around six percent to as much as 26 percent — a structural shift that has kept the market on edge ever since. The second tranche was completed in early July, with net proceeds earmarked for production expansion, strategic acquisitions, launch vehicles and future programmes. Strategically sensible, perhaps, but the dilution for existing shareholders has been palpable.

The IRIS² Paradox

Last Tuesday provided the clearest evidence yet that good news is struggling to gain traction. OHB landed a contract worth just under €1bn from Luxembourg-based satellite operator SES to develop and build 18 satellite platforms for IRIS², Europe's secure connectivity constellation. SES operates within the SpaceRISE consortium, which also counts Eutelsat and Hispasat among its members.

Should investors sell immediately? Or is it worth buying OHB SE?

The platforms, destined for medium Earth orbit, weigh around 2.6 tonnes each — considerably heavier than the roughly 700-kilogramme Galileo satellites OHB has built previously — and deliver about 15 kilowatts of power. First launches are pencilled in for 2029, with data services expected to begin in 2030. OHB plans to base all platform manufacturing in Bremen, advertising more than 120 new positions at the site and positioning the project explicitly as a growth driver for its domestic production.

The market's response was telling. Rather than rallying on the news, the stock came under renewed pressure, with particularly heavy selling on Tuesday afternoon as the SDAX weakened into the close. Since the announcement, the shares have lost around one percent — a muted reaction that analysts attribute to the dominance of technical and structural factors over fundamental developments.

Chart Signals Point Lower

The technical picture offers little comfort. The share price now sits roughly 25 percent below its 50-day moving average of €243.19, having broken through key support zones between €222 and €228. Chart analysts read the breach as a fresh sell signal with the potential to generate additional downward pressure in the near term.

The macroeconomic environment is compounding the misery. Yields on ten-year German Bunds hit a 15-year high on Thursday, while a European Central Bank rate hike in September is widely viewed as all but certain. Rising rates weigh disproportionately on capital-intensive businesses like OHB, which depend on external financing for billion-euro satellite programmes — a factor that has amplified investor nervousness in the wake of the capital increase.

A Tale of Two Trajectories

The divergence between OHB's operational trajectory and its share price performance has created an uncomfortable tension for investors. The order book is strengthening, the Bremen site is gaining industrial substance, and the IRIS² win carries clear industrial-political significance for Europe's digital sovereignty ambitions. Yet the combination of an enlarged share count, the departure of a major anchor shareholder and a broken chart has proven too heavy a burden for the equity to carry.

Whether the expanded free float eventually emerges as a stabilising force remains an open question. For now, the selling pressure shows few signs of abating, and market participants expect the stock to remain volatile until the technical sell signal is cleared — even with the long-term support of Europe's flagship satellite programme sitting squarely in the order book.

Ad

OHB SE Stock: New Analysis - 3 September

Fresh OHB SE information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated OHB SE analysis...

Disclaimer...
en | DE0005936124 | OHBS | boerse | 70048290 |